Alerts will be sent to your verified email
Verify Email
APLLTD
|
Alembic Pharma
|
Jubilant Pharmova
|
Caplin Point Lab
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
12.89 % | 7.82 % | 20.61 % |
|
5yr Avg Net Profit Margin
|
11.15 % | 6.45 % | 24.8 % |
|
Price to Book
|
3.56 | 2.65 | 9.42 |
|
P/E
|
30.68 | 35.98 | 45.43 |
|
5yr Avg Cash Conversion Cycle
|
9.46 Days | -39.98 Days | 79.85 Days |
|
5yr Average Interest Coverage Ratio
|
30.59 | 3.78 | 579.71 |
|
5yr Avg ROCE
|
15.26 % | 8.15 % | 25.27 % |
|
5yr Avg Operating Profit Margin
|
17.29 % | 16.76 % | 30.87 % |
|
5 yr average Debt to Equity
|
0.14 | 0.55 | 0.01 |
|
5yr CAGR Net Profit
|
-12.64 % | 0.08 % | 16.28 % |
|
5yr Average Return on Assets
|
9.32 % | 4.12 % | 17.7 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
69.67 % | 47.68 % | 70.56 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.06 % | -3.0 % | 1.68 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
4.04 % | 5.97 % | 0.87 % |
|
Alembic Pharma
|
Jubilant Pharmova
|
Caplin Point Lab
|
|---|